Closed-loop Automatic Oxygen Control (CLAC-4) in Preterm Infants
CLAC-4
1 other identifier
interventional
19
1 country
2
Brief Summary
Two-center, randomised controlled, cross-over clinical trial in preterm infants born at gestational age below 34+1/7 weeks receiving supplemental oxygen and respiratory support (Continous positive airway pressure (CPAP) or Non-invasive Ventilation (NIV) or Invasive Ventilation (IV)). Routine manual control (RMC) of the fraction of inspired oxygen (FiO2) will be tested against RMC supported by closed-loop automatic control (CLAC) with "slow"-algorithm and RMC supported by CLAC with "fast"-algorithm. The primary hypothesis is, that the use of the "faster" algorithm results in more time within arterial oxygen saturation (SpO2) target range compared to RMC only. The a-priori subordinate hypothesis is, that the faster algorithm is equally effective as the slower algorithm to maintain the SpO2 in the target range.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2017
CompletedFirst Submitted
Initial submission to the registry
March 30, 2017
CompletedFirst Posted
Study publicly available on registry
May 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 12, 2018
CompletedMay 15, 2018
January 1, 2017
9 months
March 30, 2017
May 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportion of time with SpO2 within target range
Comparison of proportion of time with SpO2 within target range if the infant requires supplemental oxygen and time above target range if the infant requires no supplemental oxygen between CLAC-fast and RMC (superiority hypothesis).
16 hours
Proportion of Time with SpO2 within target range
Comparison of proportion of time with SpO2 within target range if the infant requires supplemental oxygen and time above target range if the infant requires no supplemental oxygen between CLAC-fast and CLAC-slow (subordinate, non inferiority hypothesis).
16 hours
Secondary Outcomes (5)
Duration of hyperoxaemia
16 hours
Duration of hypoxaemia
16 hours
Duration of "overshoot" hyperoxaemia
16 hours
Number of "overshoot" hyperoxaemia
16 hours
Stability of cerebral oxygenation
24 hours
Other Outcomes (1)
Staff workload
24 hours
Study Arms (3)
RMC only
NO INTERVENTIONroutine manual control (RMC) of the fraction of inspired oxygen (FIO2)
CLAC slow
ACTIVE COMPARATORroutine manual control (RMC) + Closed-loop automatic oxygen control (CLAC) with 180sec WAIT-Interval ("slow" algorithm) of the fraction of inspired oxygen (FIO2)
CLAC fast
EXPERIMENTALroutine manual control (RMC) + Closed-loop automatic oxygen control (CLAC) with 30sec WAIT-Interval ("fast" algorithm) of the fraction of inspired oxygen (FIO2)
Interventions
Closed-loop automatic oxygen control is an automated, algorithm based adjustment of the fraction of inspired oxygen in relation to arterial saturation (WAIT-interval 30s).
Closed-loop automatic oxygen control is an automated, algorithm based adjustment of the fraction of inspired oxygen in relation to arterial saturation (WAIT-interval 180s).
Eligibility Criteria
You may qualify if:
- gestational age at birth \<34+1/7weeks
- invasive mechanical ventilation OR noninvasive ventilation OR continous positive airway pressure support
- parental written informed consent
You may not qualify if:
- congenital pulmonary anomalies
- diaphragmatic hernia or other diaphragmatic disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Tuebingenlead
- Johannes Gutenberg University Mainzcollaborator
- Heinen und Löwenstein GmbH & Co. KGcollaborator
Study Sites (2)
Johannes Gutenberg University Mainz
Mainz, Germany
University of Tubingen
Tübingen, 72076, Germany
Related Publications (1)
Schwarz CE, Kidszun A, Bieder NS, Franz AR, Konig J, Mildenberger E, Poets CF, Seyfang A, Urschitz MS. Is faster better? A randomised crossover study comparing algorithms for closed-loop automatic oxygen control. Arch Dis Child Fetal Neonatal Ed. 2020 Jul;105(4):369-374. doi: 10.1136/archdischild-2019-317029. Epub 2019 Sep 16.
PMID: 31527093DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Axel R Franz, MD
University Hospital Tuebingen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2017
First Posted
May 22, 2017
Study Start
March 15, 2017
Primary Completion
December 18, 2017
Study Completion
January 12, 2018
Last Updated
May 15, 2018
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share
Sharing individual participant data is not intended